Literature DB >> 23160209

A less-canonical, canonical NF-κB pathway in DCs.

Matthew S Hayden.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23160209     DOI： 10.1038/ni.2476

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  10 in total

1.  Transcription of the RelB gene is regulated by NF-kappaB.

Authors:  G D Bren; N J Solan; H Miyoshi; K N Pennington; L J Pobst; C V Paya
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

Review 2.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

Review 3.  The noncanonical NF-κB pathway.

Authors:  Shao-Cong Sun
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 4.  Lessons from mathematically modeling the NF-κB pathway.

Authors:  Soumen Basak; Marcelo Behar; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  Differential activation of NF-kappa B subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide.

Authors:  S Hofer; M Rescigno; F Granucci; S Citterio; M Francolini; P Ricciardi-Castagnoli
Journal:  Microbes Infect       Date:  2001-04       Impact factor: 2.700

6.  CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB.

Authors:  M Neumann; G Wohlleben; S Chuvpilo; B Kistler; T Wirth; E Serfling; A Schimpl
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

7.  De novo synthesized RelB mediates TNF-induced up-regulation of the human polymeric Ig receptor.

Authors:  Hilde Schjerven; Thien N Tran; Per Brandtzaeg; Finn-Eirik Johansen
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding.

Authors:  Trevor Siggers; Abraham B Chang; Ana Teixeira; Daniel Wong; Kevin J Williams; Bilal Ahmed; Jiannis Ragoussis; Irina A Udalova; Stephen T Smale; Martha L Bulyk
Journal:  Nat Immunol       Date:  2011-11-20       Impact factor: 25.606

9.  Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.

Authors:  Jeannie Q He; Brian Zarnegar; Gagik Oganesyan; Supriya K Saha; Soh Yamazaki; Sean E Doyle; Paul W Dempsey; Genhong Cheng
Journal:  J Exp Med       Date:  2006-10-02       Impact factor: 14.307

10.  Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.

Authors:  Vincent F-S Shih; Jeremy Davis-Turak; Monica Macal; Jenny Q Huang; Julia Ponomarenko; Jeffrey D Kearns; Tony Yu; Riku Fagerlund; Masataka Asagiri; Elina I Zuniga; Alexander Hoffmann
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606
  10 in total
  6 in total

Review 1.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

2.  JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.

Authors:  Jun-Ting Liou; Chin-Sheng Lin; Yu-Cheng Liao; Ling-Jun Ho; Shih-Ping Yang; Jenn-Haung Lai
Journal:  Acta Pharmacol Sin       Date:  2017-06-12       Impact factor: 6.150

3.  RelB+ Steady-State Migratory Dendritic Cells Control the Peripheral Pool of the Natural Foxp3+ Regulatory T Cells.

Authors:  Anja Döhler; Theresa Schneider; Ina Eckert; Eliana Ribechini; Nico Andreas; Marc Riemann; Boris Reizis; Falk Weih; Manfred B Lutz
Journal:  Front Immunol       Date:  2017-06-22       Impact factor: 7.561

Review 4.  NF-κB in Cancer Immunity: Friend or Foe?

Authors:  Guilhem Lalle; Julie Twardowski; Yenkel Grinberg-Bleyer
Journal:  Cells       Date:  2021-02-09       Impact factor: 6.600

5.  CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.

Authors:  Evangelia Chavdoula; David M Habiel; Eugenia Roupakia; Georgios S Markopoulos; Eleni Vasilaki; Antonis Kokkalis; Alexander P Polyzos; Haralabia Boleti; Dimitris Thanos; Apostolos Klinakis; Evangelos Kolettas; Kenneth B Marcu
Journal:  Life Sci Alliance       Date:  2019-12-02

6.  CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease.

Authors:  Yuanyuan Li; Mengyue Niu; Aonan Zhao; Wenyan Kang; Zhichun Chen; Ningdi Luo; Liche Zhou; Xiongwei Zhu; Liming Lu; Jun Liu
Journal:  J Neuroinflammation       Date:  2019-12-12       Impact factor: 8.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.